Start Submission Become a Reviewer

Reading: Carotid Baroreceptor Stimulation and Arteriovenous Shunts for Resistant Hypertension

Download

A- A+
Alt. Display

Review Articles

Carotid Baroreceptor Stimulation and Arteriovenous Shunts for Resistant Hypertension

Authors:

Nicholas Paivanas ,

University of Rochester Medical Center, Rochester, New York, US
About Nicholas
M.D.
X close

John D. Bisognano,

University of Rochester Medical Center, Rochester, New York, US
About John D.
M.D., Ph.D.
X close

John P. Gassler

University of Rochester Medical Center, Rochester, New York, US
About John P.
M.D.
X close

Abstract

Pharmacologic therapy for hypertension is effective for the majority of patients with hypertension, but there is a subset of the population with treatment-resistant hypertension who cannot achieve their blood pressure goal despite taking multiple medications. Since these patients are at increased risk of cardiovascular disease and end-organ damage, additional therapies must be considered. This review discusses several novel interventional therapies— including baroreflex activation therapy, baroreceptor stenting, and creation of an arteriovenous shunt—that may provide alternative options for blood pressure control in those with treatment-resistant hypertension. All of these therapies remain investigational, and each has its own strengths and weaknesses that will be critical to assess as they come to market.

How to Cite: 1. Paivanas N, Bisognano JD, Gassler JP. Carotid Baroreceptor Stimulation and Arteriovenous Shunts for Resistant Hypertension. Methodist DeBakey Cardiovascular Journal. 2015;11(4):223-227. DOI: http://doi.org/10.14797/mdcj-11-4-223
Published on 01 Oct 2015.
Peer Reviewed

Downloads

  • PDF (EN)